I  Portal Innovations

https://www.portalinnovations.com/





     Office Locations:

1375 West Fulton Street
Chicago, IL 60607
Phone: 773-498-5643

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Portal Innovations invests in therapeutics, med tech, and bioinformatics startups with strong leadership teams. Portal engages deeply in every aspect of the business, leveraging its network to tackle each company's specific challenges and lead them to successful Series A investments with VCs and strategic investors. Walder Ventures (see profile) is the founding sponsor of Portal Innovations.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    John Flavin CEO
    Nader Elrashidy Chief Business Officer
    Steven Lehmann Director
    Yuan Zhang Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/23/2024


      March Biosciences


      TX


      $28,400,000


      Series A


     

    Portfolio companies include:


      ARase Therapeutics


      Cardiosense
        web link


      Dimension Inx
        web link


      Grove Biopharma


      March Biosciences
        web link


      Rhaeos


      Syntis Bio


      Zylem Biosciences


     

    Recent News: